Kilitch Drugs (India) Limited is an India-based pharmaceutical manufacturing company. The Company is mainly engaged in the development and operations of the pharmaceutical business. Its services range from manufacturing to marketing a host of formulations in all dosage forms. The Company offers products in the categories of Parenteral and Nasal Products, Oral, Effervescent, Nutritional Products, Medical Devices, and Cosmetics and Herbal Products. It offers products that help in gastroenterology, anti-inflammatory, anti-malaria, diagnostics, uterine stimulants, veterinary and many more areas in the form of ampoules & vials. Its range of oral formulations includes tablets, capsules, dry syrups and oral powders. It provides a range of cosmetics ranging from oil, lotion, liquid to cream and paste in the skin care, personal care and hair care categories. It offers a medical device, namely, the C-Seal. ROIPAR, ROIVIT, PH-7, C-SEAL, SRO-KIT, 9-VIT, HPURE are their product offerings.
Kilitch Drugs (India) Ltd FAQs
How to Buy Kilitch Drugs (India) Ltd Share?
To purchase Kilitch Drugs (India) Ltd shares, you can open a Demat & Trading account through a broker or financial institution. Once your account is set up and funded, search for Kilitch Drugs (India) Ltd (ticker symbol: KILITCH) on the trading platform provided by your broker and purchase the shares.
The stock price of Kilitch Drugs (India) Ltd as of 07 Oct 2025 is ₹361.93
What is the Market Cap of Kilitch Drugs (India) Ltd?
Market capitalisation represents the total market value of a company's outstanding shares. As of 07 Oct 2025, Kilitch Drugs (India) Ltd (ticker symbol: KILITCH) has a market capitalisation of approximately ₹6,10,00,00,000.00
What is the PE and PB ratio of Kilitch Drugs (India) Ltd?
Kilitch Drugs (India) Ltd Ltd's price-to-book ratio as of 07 Oct 2025 is 3.31, reflecting the market's valuation compared to its asset value. As of 07 Oct 2025, the trailing twelve months P/E (price-to-earnings) ratio is 39.86, indicating the market values the company at around ₹39.86 for every ₹1 of earnings
What is the 52 Week High and Low of Kilitch Drugs (India) Ltd Share?
Kilitch Drugs (India) Ltd Ltd (KILITCH) hit its 52-week high at ₹500.00, and its 52-week low at ₹299.95.